Ardent Health Partners, LLC (NYSE:ARDT - Get Free Report) has been assigned a consensus rating of "Buy" from the twelve ratings firms that are covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating on the company. The average 1-year target price among brokerages that have covered the stock in the last year is $21.82.
Several research firms recently issued reports on ARDT. Stephens reaffirmed an "overweight" rating and set a $24.00 price target on shares of Ardent Health Partners in a research note on Thursday, September 19th. Royal Bank of Canada reiterated an "outperform" rating and set a $23.00 price objective on shares of Ardent Health Partners in a research note on Thursday, November 14th. Bank of America downgraded shares of Ardent Health Partners from a "buy" rating to a "neutral" rating and dropped their target price for the stock from $22.00 to $19.00 in a research report on Wednesday, November 6th. KeyCorp initiated coverage on shares of Ardent Health Partners in a research report on Friday, October 11th. They set an "overweight" rating and a $24.00 price target on the stock. Finally, Leerink Partners lifted their price target on Ardent Health Partners from $23.00 to $25.00 and gave the stock an "outperform" rating in a research note on Tuesday, November 12th.
Check Out Our Latest Research Report on Ardent Health Partners
Institutional Investors Weigh In On Ardent Health Partners
Large investors have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets acquired a new stake in shares of Ardent Health Partners in the third quarter valued at approximately $42,000. Financial Management Professionals Inc. acquired a new stake in Ardent Health Partners in the 3rd quarter valued at approximately $50,000. MetLife Investment Management LLC acquired a new stake in Ardent Health Partners in the 3rd quarter valued at approximately $135,000. Quadrature Capital Ltd bought a new stake in Ardent Health Partners during the 3rd quarter valued at $229,000. Finally, Barclays PLC acquired a new position in Ardent Health Partners during the 3rd quarter worth $385,000.
Ardent Health Partners Stock Performance
Ardent Health Partners stock traded down $0.01 during midday trading on Friday, hitting $16.69. 147,209 shares of the company were exchanged, compared to its average volume of 347,231. Ardent Health Partners has a fifty-two week low of $14.57 and a fifty-two week high of $20.72. The stock has a fifty day simple moving average of $17.41. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91.
Ardent Health Partners Company Profile
(
Get Free ReportArdent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Further Reading
Before you consider Ardent Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.
While Ardent Health Partners currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
